Navigation Links
TGen's Dr. Von Hoff wins award for cancer research
Date:3/18/2009

PHOENIX, Ariz. March 18, 2009 Dr. Daniel Von Hoff, Physician-In-Chief of the Translational Genomics Research Institute (TGen), has won an award recognizing his achievements in cancer research.

Dr. Von Hoff, who also is Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare, will be recognized in the category of Health Care Research in a special report this month in Arizona Business Magazine. Dr. Von Hoff was honored March 4 at the magazine's 2009 Health Care Leadership Awards at the Ritz Carlton Phoenix.

This is the second major award in recent months for Dr. Von Hoff, a world-renowned cancer scientist and one of the leading experts in pancreatic cancer. In November, Dr. Von Hoff was named Arizona's Community Service Leader of the Year at the 2008 Governor's Celebration of Innovation, presented annually for contributions to Arizona's technology industry through relentless community involvement, leadership, visibility and excellence in economic development activity.

For more than 30 years, Dr. Von Hoff has dedicated his time and experience to the study of cancer and treatment methods. Arizona Business Magazine cited his:

  • International leadership in bringing to patients new anti-cancer agents many of which have been shown to increase patient survival.

  • Study of pancreatic and other forms of cancer.

  • Dedication to teaching.

  • Entrepreneurial research efforts, which have led to 12 patents.

Through the three-year-old partnership between TGen and Scottsdale Healthcare, Dr. Von Hoff leads a nearly 40-member staff in the research and treatment of cancer. TCRS at Scottsdale Healthcare is conducting 35 ongoing studies, involving the treatment of many patients with advanced cancer. The alliance works to identify new anti-cancer agents, and strives to bring diagnostic and treatment options to patients as fast as possible.

Dr. Von Hoff earned his medical degree from Columbia College of Physicians and Surgeons. He held an internship and residency at the University of California, San Francisco; conducted four years of cancer research at the National Cancer Institute; and worked as a faculty member at the University of Texas.

In Arizona, he has worked as Director of the Arizona Cancer Center in Tucson and as a Clinical Professor at the University of Arizona College of Medicine.

Dr. Von Hoff holds a presidential appointment to the National Cancer Advisory Board, is widely published and has been a keynote speaker at numerous national and international medical and scientific conferences.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. DOE awards UGA $3.1 million to support complex carbohydrate study nationwide
2. Lehigh researcher awarded $1.8 million NIH grant
3. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
4. Dr. King receives IADR Craniofacial Biology Research Award
5. Christopher McCulloch receives the IADR Research in Oral Biology Award
6. IADR Wilmer Souder Award presented to University of Colorado professor
7. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
8. Oxfords Dr. Rosalind Rickaby receives 2009 Rosenstiel Award
9. Sea Grant awards $820,000 for research under EPAs Long Island Sound study
10. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
11. Lincoln Park Zoo scientists awarded National Institutes of Health grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Research and Markets ... the addition of the "Implantable Biomaterials Market Analysis ... report to their offering. Report Highlights: ... on current and future market trends to identify the investment opportunities ... base numbers Key market trends across the business segments, ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... ... 19, 2017 , ... FireflySci Inc. is a go-getter type of company that ... accounted to two main factors. The first is the amazing customer service that ... FireflySci products all around the world. , 2016 was a tremendous sales year for ...
(Date:1/19/2017)... 18, 2017 Acupath Laboratories, Inc., a leading ... of an Executive Committee that will guide the company,s ... John Cucci , a 15-year veteran of the ... Business Development to Chief Sales Officer .  Prior ... in senior sales leadership roles at several leading lab ...
Breaking Biology Technology: